Overview

Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism

Status:
Terminated
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
Comparison of Oral anticoagulants (warfarin, apixaban and rivaroxaban) for extended VEnous Thromboembolism.
Phase:
Phase 4
Details
Lead Sponsor:
Duke University
Collaborator:
Patient-Centered Outcomes Research Institute
Treatments:
Anticoagulants
Apixaban
Rivaroxaban
Warfarin